Also because of the practical reasons, the pollution problem and Chinese almost raw materials and generic pharmaceutical industry always parallel

Also because of the practical reasons, the pollution problem and Chinese almost raw materials and generic pharmaceutical industry always parallel, can not find a fundamental solution to the.

Public data shows, in recent years, almost all enterprises are facing the embarrassment of antibiotics because of pollution problems are named fines, Harbin Pharmaceutical shares, federal pharmaceutical, pharmaceutical and large pharmaceutical companies have in the environmental protection department supervision rectification list. Even, some enterprises after rectification is also difficult to reach the standard, often “the list”, such as the federal pharmaceutical, since 2004 twelve years, has nine times by the environmental protection department criticized, limiting the production cuts or even shut down.

The pollution problems have been exposed in the case of Harbin, Harbin pharmaceutical company said in the announcement, “in recent years, the company has invested 400 million yuan for cleaner production and environmental management, mainly the construction of wastewater treatment and sewage treatment, odor, noise, etc. the boiler flue gas pollution treatment facilities. The annual operating costs of various environmental protection facilities in more than 5000 yuan.”

But even for the relocation to eradicate the pollution problem of investment, Harbin in its 2010 annual report also said pessimistically, due to different construction of huge investment, the added value of raw materials products is low, meager profit margins, is expected to put into operation after 2~3 years will not have a competitive advantage, so easily cause enterprises in a loss situation, causes the enterprise to survive the consequences”.